Approved & launched recently Psychiatry fluvoxamine (LUVOX®, DEPROMEL®) Major depressive disorders (MDD) & obsessive-compulsive disorders (OCD) (Japan)
a Psychiatry LUVOX® Tablets OCD pediatric (US)
Cardiology TEVETEN® Hypertension (US & Europe)
Cardiology ACEON® Hypertension (US)
Hormone replacement ANDROGEL® Testosterone replacement therapy for men (US)
Hormone replacement FEMOSTON® Combinations Prevention of osteoporosis (Europe)
 Filed Immunology Cell culture technology for influenza vaccines Influenza prophylaxis
Hormone replacement ESTROGEL® Hormone replacement Therapy (HRT) for women (US)
Phase III Psychiatry fluvoxamine Controlled Release (CR) OCD, Social Anxiety (global)
Cardiology eprosartan plus hydrochlorothiazide Teveten® combination tablet hypertension (global)
Gastroenterology ciIansetron Irritable bowel syndrome (IBS)
Gastroenterology CREON® Pancreatic exocrine insufficiency (Japan)
Hormone replacement PRESOMEN® Combinations Vasomotor symptoms and prevention of osteoporosis (Europe)
Hormone replacement ESTRATEST® Loss of Sexual Interest (US)
Hormone replacement Estrogen plus progestogen combined in a skin patch Vasomotor symptoms (US)
Hormone replacement Combigel of estrogen plus progestogen HRT for women, a combination skin gel product (Europe)
Imunnology Virosomal influenza vaccine Influenza prophylaxis
Phase ll Psychiatry DU125530 Major depressive disorders
Psychiatry and Neurology DU127090 Schizophrenia and Parkinsons disease
Psychiatry and Neurology SLV308 Parkinsons disease, Panic attacks and major depressive disorders
Cardiology SLV306 Hypertension and congestive heart failure
Cardiology tedisamil (intravenous/oral) Atrial Fibrillation
Gastroenterology KC11458 Delayed Gastric Emptying
Phase l Psychiatry SLV310 and SLV313 Psychosis


Phase I
– Evaluation of clinical pharmacology, performed in volunteers

Phase II
– Determination of dose and initial evaluation of efficacy, performed in
relatively small numbers of patients

Phase III – Large comparative study in patients to establish clinical benefit (in which the compound is compared to placebo and/or an established treatment) [back to top]

Leave a comment

Your email address will not be published. Required fields are marked *